Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tafinlar
Pharma
Novartis plots 139 layoffs in NJ, largely affecting field sales
Novartis is laying off 139 staffers at its U.S. headquarters in New Jersey as it retools its field sales teams ahead of multiple expected launches.
Fraiser Kansteiner
Nov 26, 2024 4:30pm
Daiichi Sankyo scores $182M from Novartis patent settlement
Dec 6, 2023 11:13am
J&J-Legend, Takeda, Merck and more—Fierce Pharma Asia
Oct 7, 2022 10:50am
Novartis ordered to pay Daiichi $177.8M and Tafinlar royalty
Oct 4, 2022 11:40am
Novartis' targeted cancer combo wins tumor-agnostic FDA nod
Jun 23, 2022 8:15am
AstraZeneca, Takeda, Biocon-Viatris and more—Fierce Pharma Asia
Jul 30, 2021 5:17am
